Drug derived from red wine may combat obesity, study says

11/5/2008 | BBC

Sirtris Pharmaceuticals' drug candidate SRT1720 partially prevented weight gain in mice on a high-fat diet when given at low dosage, and it completely prevented weight gain when given in high doses over 10 weeks, French researchers reported. The treatment, which is derived from the red-wine extract resveratrol, also raised blood-sugar tolerance and insulin sensitivity, according to the study.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX